Related Experiment Video
Updated: Jun 13, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Canadian Paediatric Surveillance Program: Two years of a system for investigating unusual paediatric disorders
1Division of Disease Surveillance, Bureau of Infectious Diseases, Laboratory Centre for Disease Control, Ottawa, Ontario.
Insights
The Canadian Paediatric Surveillance Program (CPSP) monitors rare childhood diseases. It collects data from pediatricians across Canada to track public health conditions.
Area of Science:
- Pediatrics
- Public Health
- Epidemiology
Background:
- The Canadian Paediatric Surveillance Program (CPSP) was established in 1996.
- It is a collaboration between the Canadian Paediatric Society (CPS) and the Laboratory Centre for Disease Control (LCDC).
- Oversight is provided by a steering committee with expertise in paediatrics, epidemiology, genetics, and public health.
Purpose of the Study:
- To actively surveil rare and unusual paediatric conditions of public health importance in Canada.
- To collect timely data on the incidence of specific paediatric diseases.
- To facilitate research and collaboration on childhood health issues.
Main Methods:
- Monthly report cards were sent to all clinically active paediatricians in Canada.
- Paediatricians reported the number of new cases for selected conditions, including nil reports.
- Detailed case report forms were used for follow-up, with data analyzed by principal investigators.
Main Results:
- In its initial two years, the program reported on seven rare paediatric conditions.
- The system successfully gathered data on paediatric disease incidence through active reporting.
- The program demonstrated feasibility for ongoing surveillance of public health priorities.
Conclusions:
- The CPSP is an effective active surveillance system for rare paediatric conditions in Canada.
- The program's methodology allows for the monitoring of public health concerns in children.
- Future plans include international collaboration and expansion of surveillance capabilities.
Abstract:
The Canadian Paediatric Surveillance Program (CPSP) is an active surveillance program for rare and unusual paediatric conditions of public health importance in Canada. The program was initiated in 1996 as a joint venture of the Canadian Paediatric Society (CPS) and the Laboratory Centre for Disease Control (LCDC), and is currently overseen by a steering committee representing the fields of paediatrics, epidemiology, genetics and public health. In the first two years of activity seven conditions were reported to the program via a monthly report card mailed to all clinically active paediatricians in Canada. Respondents were asked to indicate on the card the number of new cases seen for each condition and to ensure that all nil reports were also returned. Case reports were followed up with detailed report forms requesting case specific information which, when returned to the CPS, were forwarded to the principal investigator for assessment and analysis. Studies are for a minimum of one year, and new conditions may be included in the program following review by the steering committee and confirmation of ethical approval. Future development of the program includes linkage with a growing international network of paediatric surveillance units and the potential for collaboration in international studies of conditions of common interest.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Principles of Disease Surveillance
Investigation of Disease Outbreaks
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
